We have identified a GDAY motif in the C-terminal domain of guanylyl cyclase (guanylate cyclase)/NPRA (natriuretic peptide receptor A) sequence, which serves a dual role as an internalization signal and a recycling signal. To delineate the role of the GDAY motif in receptor internalization and sequestration, we mutated Gly 920 , Asp 921 and Tyr 923 to alanine residues (GDAY/ AAAA) in the NPRA cDNA sequence. The cDNAs encoding wild-type and mutant receptors were transfected in HEK-293 cells (human embryonic kidney 293 cells). The internalization studies of ligand-receptor complexes revealed that endocytosis of 125 I-ANP by HEK-293 cells expressing G920A, Y923A or GDAY/ AAAA mutant receptor was decreased by almost 50 % (P < 0.001) when compared with cells expressing the wild-type receptor. However, the effect of D921A mutation on receptor internalization was minimal. Ligand-mediated down-regulation of G920A, Y923A and GDAY/AAAA mutant receptors was decreased by 35-40 % when compared with wild-type NPRA. Subsequently, the recycling of internalized D921A and GDAY/AAAA mutant receptors from the intracellular pool was decreased by more than 40 + − 4 % when compared with wild-type NPRA. Recycling of G920A and Y923A mutant receptors was also decreased, but to a significantly lesser extent compared with the D921A or GDAY/AAAA mutant receptors. We conclude that the Gly 920 and Tyr 923 residues within the GDAY consensus motif are necessary for internalization, and that residue Asp 921 is important for recycling of NPRA. The current results provide new evidence for a dual role of the GDAY sequence motif in ligandmediated internalization, recycling and down-regulation of a single-transmembrane receptor protein NPRA.
INTRODUCTION
ANP (atrial natriuretic peptide) is a member of the natriuretic peptide hormone family, which comprises ANP, BNP (brain natriuretic peptide) and CNP (C-type natriuretic peptide), each derived from a separate gene [1] . Natriuretic peptides elicit a number of vascular, renal and endocrine effects, resulting in the maintenance of blood pressure and extracellular fluid volume [2] [3] [4] [5] . ANP and BNP are primarily synthesized in the granules of heart, circulate in the plasma and display maximum variability in the primary structure, whereas CNP is largely present in the endothelial cells and is highly conserved among the species. Three subtypes of natriuretic peptide receptors have been identified, namely NPRA, NPRB and NPRC (natriuretic peptide receptors A, B and C respectively). NPRA and NPRB contain an extracellular ligand-binding domain, a single transmembrane region and intracellular protein kinase-like and guanylyl cyclase (guanylate cyclase) catalytic domains [6, 7] . ANP and BNP activate NPRA, which produces second messenger cGMP in response to hormone binding. CNP activates NPRB, which also produces cGMP; however, all three natriuretic peptides indiscriminately bind to NPRC, which lacks guanylyl cyclase activity [8] [9] [10] . NPRA is considered to be the biological receptor of ANP and BNP, since most of the physiological effects of these peptide hormones are triggered by the generation of second messenger cGMP [11, 12] . The activity andexpressionofNPRA,assessedprimarilythroughANP-dependent guanylyl cyclase activity and cGMP accumulation, are regulated by a number of factors, including the ligand itself [13] [14] [15] .
Recent studies with Npr1 (coding for NPRA) gene-disruption and gene-duplication mouse models have revealed the hallmark significance of NPRA in lowering arterial pressures and protecting against renal and cardiac pathophysiological functions [16, 17] .
On ligand binding, NPRA dimerizes and the guanylyl cyclase catalytic domain probably becomes activated [18] . ANP binding also triggers efficient NPRA internalization and trafficking into intracellular compartments [13, 15, 19, 20] . ANP is subsequently delivered, probably through endosomes, to the lysosomal compartments, where it is largely degraded; however, a population of ligand-receptor complexes escapes the lysosomal compartment, and the receptor recycles back to the plasma membrane. So far, the structural determinants of the receptor activation and signalling pathways that control the internalization and subsequent intracellular routing of NPRA are not well understood. We have suggested in a previous study that a sorting mechanism partitions the incoming bound ligand-receptor complexes into one of the two major intracellular routes [15] . First, a degradative route leads to intracellular catabolism and release of the degraded ligand in addition to returning most of the internalized receptors to the cell surface. Secondly, a retroendocytosis pathway determines the release of the intact ligand as well as receptor recycling from intracellular compartments to the plasma membrane. However, the signals in the NPRA sequence that control and specify its endocytosis pathways have not been determined.
In the present study, we have performed mutations in the Cterminal domain of NPRA and we have expressed both wildtype and mutant receptors in HEK-293 cells (human embryonic kidney 293 cells). The region encoded in the C-terminal domain of NPRA contains one copy of the tetrameric sequence GDAY. In the present study, we sought to determine whether these residues play a role in ligand-mediated trafficking and down-regulation of NPRA. Here, we show for the first time that point mutations in the GDAY sequence of NPRA result in defective internalization and subsequent recycling of this receptor protein. Our results reveal that information residing within the GDAY sequence is important for receptor internalization and trafficking from the cell surface to intracellular compartments.
MATERIALS AND METHODS

Materials
ANP (rat-28) was purchased from Peninsula Laboratories 
Site-directed mutagenesis of NPRA
Murine cDNA encoding NPRA [6] was subcloned into the expression vector p cDNA3 as described previously [21] . The individual amino acids in the GDAY sequence along with two additional residues on each side of this motif were mutated as follows : the four amino acids Thr  918 , Ile  919 , Gly  920 and Asp   921   mutated to Ala, Ala  922 mutated to Ile and the three amino acids  Tyr  923 , Met  924 and Val 925 mutated to Ala. The oligonucleotidemediated mutagenesis was performed using the Quik Change site-directed mutagenesis kit. Specifically, the sequence of the GDAY/AAAA mutagenic sense primer was 5 -AAGGTAGAGA-CCATTGCTGCTGCTGCTATGGTGGTATCAGGG-3 and that of the antisense primer was 5 -CCCTGATACCACCATAGC-AGCAGCAGCAGCAATGGTCTCTACCTT-3 , where the underlined nucleotides indicate mutations G920A (Gly 920 → Ala), D921A and Y923A respectively. The residue Ala 922 of the GDAY motif was kept unchanged unless otherwise stated. The integrity of the mutated plasmid sequence was confirmed by doublestranded DNA sequencing in the mutagenized region of NPRA. The nucleotide sequence was determined at the Center for Gene Therapy Sequencing Core Facility, Tulane University School of Medicine.
Cell culture and stable transfection of wild-type and mutant NPRA HEK-293 cells were grown in 6 cm 2 culture dishes containing DMEM (Dulbecco's modified Eagle's medium), supplemented with 10 % (v/v) FBS (fetal bovine serum). Initially, subconfluent cells were transfected with wild-type and GDAY/AAAA mutant NPRA cDNAs using Lipofectamine TM and LT-1 reagents. To establish the stably expressing receptor cell lines, 400 µg/ml Geneticin was added to the culture medium after transfection. Antibiotic-resistant clones were isolated and established for receptor expression using 125 I-ANP binding and the cGMP assay as described in [15] . Cells were maintained in monolayer culture in an atmosphere of 5 % CO 2 and 95 % O 2 , and the culture medium was replaced on alternate days.
Cell-surface receptor binding assay
Both wild-type and mutant recombinant HEK-293 cells were grown in 6 cm 2 culture dishes. After confluence, cells were washed with DMEM containing 0.1 % BSA and labelled with 125 I-ANP in the absence or presence of 100-fold excess molar concentrations of unlabelled ANP. After completion of binding at 4
• C, the unbound 125 I-ANP was removed from the dishes by four washes (2 ml each) with ice-cold assay medium. To determine the cell-surface-associated radioactivity, the acid-wash procedure as described in [21] was used. After binding was completed, each culture dish received 1 ml of ice-cold acidic buffer (50 mM glycine/100 mM NaCl, pH 3.8) at 4
• C. After 2 min, the acid eluate from the dish was collected and each dish received another 1 ml of ice-cold glycine acidic buffer to wash the cells. Both eluate solutions were combined to determine the acid-sensitive radioactivity. Cells were then dissolved in 0.5 M NaOH to determine the acid-resistant radioactivity. Acid-sensitive radioactivity was used as an index of the cell-surface-bound 125 I-ANP, and acid-resistant radioactivity was used as a measurement of the internalized ligand-receptor complexes.
Receptor internalization and sequestration
HEK-293 cells expressing either wild-type or mutant NPRAs were allowed to bind 125 I-ANP at 4
• C for 60 min. The unbound 125 I-ANP was removed by washing the cells with ice-cold assay medium. The total cell-associated radioactivity was determined by dissolving cells in 0.5 M NaOH, and counting the radioactivity in the cell lysate, which represented the initial zero-time control value of 100 %. Internalization of ligand-receptor complexes was allowed by quickly warming the cells at 37
• C. At the indicated time periods, the culture dishes were removed from the medium at 37
• C, placed at 4 • C, and the media were collected. As described above, the cell-surface-associated 125 I-ANP radioactivity was removed by washing the cells with ice-cold glycine acidic buffer (pH 3.8) at 4
• C. After the acid wash, the internalized 125 I-ANP radioactivity was measured by dissolving the cells in 0.5 M NaOH. To quantify the rate of degradation of ligand-receptor complexes in the lysosomal compartments, cells expressing wildtype and mutant receptors were pretreated with lysosomotropic agents such as monensin (50 µM), chloroquine (200 µM) and ammonium chloride (10 mM) at 37
• C for 1 h. Then, cells were allowed to bind 125 I-ANP at 4
• C for 1 h, washed with assay medium and re-incubated in the fresh medium at 37
• C. The treatment with lysosomotropic agents was maintained throughout the entire ligand binding and internalization periods of the experiment. It should be noted that lysosomotropic agents did not alter the binding capacity of the ligand to intact HEK-293 cells at 4
• C. Quantitative analyses of intact and degraded ligands released into the culture medium were performed by precipitating the medium with 10 % (w/v) trichloroacetic acid containing 200 µg/ ml BSA as the carrier by our previously described methods [13] . The 125 I-ANP recovered in the trichloroacetic acid precipitate was considered to be the intact ligand, and those in the supernatant were regarded as degraded ligand products. mutant NPRAs were washed with an ice-cold binding assay medium and treated with trypsin (0.025 %) for 10 min at 4
• C. To stop the trypsin reaction, cells were treated with a soya-bean trypsin inhibitor (200 µg/ml), washed quickly three times with assay medium and then re-incubated in the fresh medium. In both trypsin-treated and untreated cells, 125 I-ANP binding was determined as described above. It should be noted that treatment of cells with trypsin for 10 min at 4
• C essentially abolished the cellsurface binding of 125 I-ANP and did not cause any significant cell detachment from the culture dishes.
Quantitative assessment of intracellular wild-type and mutant receptors in solubilized recombinant HEK-293 cells Total wild-type and mutant receptor contents were quantified by solubilizing HEK-293 cells in a buffer containing 20 mM Hepes (pH 7.4), 1.5 M NaCl, 1 % Triton X-100, 15 % glycerol, 1 mM EDTA and 10 µg/ml each of leupeptin and aprotinin. The mixture was centrifuged for 5 min at 1000 g to remove the insoluble material and then re-centrifuged at 100 000 g for 1 h to obtain a clear supernatant. The 125 I-ANP binding activity was assayed at 25
• C for 1 h by adding 50 µl of solubilized supernatant to 400 µl of binding buffer containing 50 mM Tris/HCl (pH 7.4), 0.15 M NaCl, 5 mM MgCl 2 , 0.1% BSA, 0.5 mg/ml bacitracin and 1 mM 125 I-ANP as described previously [15] . Non-specific binding was determined by the addition of 100-fold excess molar concentrations of unlabelled ANP. The radiolabelled ligand bound to solubilized receptors was precipitated by adding 0.25 % bovine γ -globulin and 2.5 ml of 10 % (w/v) poly(ethylene glycol)-8000 in 20 mM Tris/HCl (pH 7.4) and 0.15 M NaCl. The mixture was filtered under vacuum through Whatman GF/B filters treated with 0.3 % (w/v) polyethyleneimine. To quantify only intracellular receptors, cells were first trypsin-treated to degrade total receptor binding activities on the cell surface, followed by quantification of intracellular receptors.
Metabolic labelling and immunoprecipitation
HEK-293 cells expressing wild-type or mutant receptors were plated in 6 cm 2 dishes containing DMEM supplemented with 10 % FBS. A pulse-chase experiment was performed by washing the subconfluent monolayer cells twice with HBSS (Hanks balanced salt solution) and incubating at 37
• C with 2 ml of methionine-free DMEM, supplemented with 1 µM unlabelled methionine, 10 % FBS and 0.14 mCi/ml [ 35 S]methionine. After 1 h, the pulse medium was removed. The cells were washed once with HBSS and then with 2 ml of chase medium consisting of normal DMEM and 10 % FBS, and incubated in fresh medium at 37
• C for 18 h. Then, cells were washed once with HBSS and scraped in solubilizing buffer [20 mM Hepes (pH 7.4), 150 mM NaCl, 1 % Triton X-100, 10 % glycerol, 5 mM EDTA, 1 mM PMSF and 10 µg/ml each of aprotinin and leupeptin]. The cell lysate was stirred for 30 min at 4
• C and then the mixture was centrifuged for 5 min at 1000 g to remove the insoluble material. The supernatant was re-centrifuged at 100 000 g for 1 h to obtain a clear solution containing the solubilized receptors by standard methods [21] .
For immunoprecipitations, equal amounts of protein (100 µg) obtained from the recombinant HEK-293 cells expressing either wild-type or mutant receptors were incubated with 1:400 dilution of NPRA antiserum at 4
• C for 4 h as described previously [21] . The immunocomplex was precipitated with Protein A-agarose and the non-specific proteins were removed by washing the precipitated material four times with RIPA buffer containing 20 mM Tris/HCl (pH 7.4), 150 mM NaCl, 1 % sodium deoxycholate, 1 % Triton X-100 and 0.2 % SDS as described previously [21] .
The content was dissolved in sample buffer, boiled for 5 min, and the immunoprecipitated proteins were analysed by SDS/ PAGE (7.5 % polyacrylamide) under reducing conditions. Electrophoresis was performed at a constant current of 25 mA until the Bromophenol Blue front reached the bottom of the gel. Proteins in the gel were stained with Coomassie Brilliant Blue R-250. After destaining, the gel was dried and fluorographed at − 70
• C using a Kodak X-Omat film and Cronex Lightening Plus intensifying screen (DuPont, Boston, MA, U.S.A.). The proteins used for standard molecular-mass (relative molecular mass) calibration were as follows: myosin (M r 205 000), β-galactosidase (M r 116 000), phosphorylase B (M r 97 000), BSA (M r 67 000), ovalbumin (M r 45 000) and carbonic anhydrase (M r 29 000).
Statistical analysis
The dissociation constant (k d ) and the receptor density (B max ) in recombinant HEK-293 cells expressing wild-type or GDAY/ AAAA mutant receptor were determined by Scatchard plot analysis using a computer program (Ligand). Results are presented as means + − S.E.M. for triplicate determinations in at least three to four separate sets of experiments. Statistical significance was ascertained by the use of an unpaired t test. Figure 1 shows the experiment in which alanine was substituted for each of the amino acids in the conserved region from positions 918 to 925 in the C-terminal domain of NPRA. In each experiment, we compared the cells expressing one or more of the NPRA mutations with the cells expressing wild-type receptor. Two of the alanine substitutions lowered internalization by almost 50 % of the control value ( Figure 1A ). Three of the amino acids, including Gly 920 , Asp 921 and Tyr 923 , seem to be important in the GDAY motif for receptor internalization. When the alanine residue of the GDAY sequence was replaced with a leucine residue, we did not observe any diminution of internalization when compared with the wild-type receptor. The substitution of two amino acids on either side of GDAY motif did not show any effect on the internalization of NPRA ( Figure 1A ). In addition to a single alanine substitution, we also performed mutations in which two residues were substituted with alanine residues simultaneously ( Figure 1B ). The substitution of Gly 920 or Tyr 923 with alanine residues individually or simultaneously decreased the internalization of the mutant receptor by almost 50 % when compared with wild-type NPRA. The substitution of Asp 921 with an alanine residue decreased the internalization of NPRA by only 20 %, indicating that Asp 921 has only a minimal effect on internalization; however, Ala 922 does not seem to be important for receptor internalization. In subsequent studies, single mutations of Gly 920 , Asp 921 and Tyr 923 to alanine (G920A, D921A and Y923A and/or a triple mutation of GDAY (GDAY/AAAA) were utilized to determine the effect of the GDAY motif on the kinetics of internalization and/or recycling of NPRA.
RESULTS
Internalization of NPRA containing alanine mutations at different positions in the C-terminal GDAY motif
Expression and binding competition analyses of wild-type and mutant receptors in recombinant HEK-293 cells
Confluent HEK-293 cells expressing wild-type or mutant NPRA were exposed to 125 I-ANP at 4
• C for 1 h. After washing the free ligand, the cell-associated 125 I-ANP radioactivity was determined. The results presented in Figure 2 demonstrate the competition binding curves with increasing concentrations of unlabelled ANP. The GDAY/AAAA mutant NPRA displayed a dose-response curve for 125 I-ANP binding similar to that seen for the wildtype receptor. As determined by Scatchard plot analysis using the computer program, recombinant HEK-293 cells harbouring wildtype and GDAY/AAAA mutant receptors expressed 1.87 × 10 6 and 1.89 × 10 6 receptor sites/cell respectively. Receptor-binding affinity was comparable in both cell lines, with K d ∼ 2.4 × 10 −10 M (Table 1 ). In the initial studies, two independent HEK-293 recombinant cell lines harbouring wild-type, G920A, D921A, Y923A or GDAY/AAAA receptors were utilized for the functional studies, and each clonal cell line yielded comparable binding results (results not shown). The bound 125 I-ANP-NPRA complexes were measured to examine the kinetics of internalization, trafficking and sequestration of wild-type, G920A, D921A, Y923A and triple-mutant GDAY/ AAAA receptors in stably expressing HEK-293 cells. The radioligand 125 I-ANP was bound to the cell-surface receptors during incubation at 4
• C and then allowed to internalize after warming the cells at 37
• C. The time course of 125 I-ANP internalization was determined for wild-type, G920A, D921A, Y923A and GDAY/ AAAA recombinant cell lines. The results presented in Figure 3 show that 125 I-ANP bound to both wild-type and mutant NPRA was rapidly internalized, and total intracellular radioactivity increased to the maximum levels in 15 min at 37 • C. Results are expressed as a percentage of the total cell-associated radioactivity that was internalized at each time point. The initial rate of ligand internalization was clearly decreased by almost 50 % (P < 0.001) in recombinant HEK-293 cells expressing G920A, Y923A and triple-mutant GDAY/AAAA receptors when compared with recombinant cells expressing wild-type receptor. At 15 min, an internalization defect of 46 + − 3, 49 + − 4 and 52 + − 4 % was observed in cells expressing G920A, Y923A and GDAY/AAAA mutant NPRA respectively. However, the D921A mutant receptor showed only an 18 % reduction in internalization when compared with wild-type NPRA.
We determined the cell-surface-associated, internalized and released 125 I-ANP radioactivity in HEK-293 cells expressing either wild-type or GDAY/AAAA mutant receptor by the acidwash procedure. During the internalization period, culture dishes in replicates were removed from the medium at 37
• C and placed at 4
• C, and media were collected. Cells were washed once with HBSS and then treated with glycine acidic buffer (pH 3.8) at 4
• C to release the cell-surface-associated 125 I-ANP at the indicated time periods. HEK-293 cells expressing wild-type NPRA showed a rapid internalization of ligand-receptor complexes, with almost 60-65 % of the receptors internalized inside the cells after a 5 min incubation at 37
• C. On the contrary, only 30-35 % of the receptors were internalized in HEK-293 cells expressing GDAY/AAAA mutant receptor for the same incubation time periods ( Figure 4A ). The amount of internalized receptor decreased rapidly after 5 min of incubation at 37
• C. The population of internalized ligand-receptor complexes in recombinant HEK-293 cells expressing GDAY/AAAA mutant NPRA was decreased by almost 50 % after a 5 min incubation at 37
• C when compared with HEK-293 cells expressing wild-type NPRA 2 dishes expressing wild-type or mutant receptors were allowed to bind 125 I-ANP at 4 • C for 1 h. Cells were washed four times, each with 2 ml of assay medium, to remove the unbound ligand and then re-incubated in fresh medium at 37 • C. At the indicated time points, dishes were transferred at 4 • C and the media were collected. The cell-surface-associated (acid-sensitive) radioactivity was eluted with glycine acidic buffer (pH 3.8) and cells were dissolved in 1 M NaOH to measure the internalized (acid-resistant) radioactivity. Cell-surface-associated (A), internalized (B) and released (C) 125 I-ANP radioactivity was determined in the acid eluate, cell extract and culture medium respectively as described in the Materials and methods section. Results represent the means + − S.E.M. for three to four independent experiments with triplicate dishes in each replicate.
( Figure 4B ). The wild-type recombinant HEK-293 cells accumulated intracellular 125 I-ANP radioactivity at much higher levels when compared with HEK-293 cells expressing GDAY/AAAA mutant NPRA. This difference was noted because of the differential rates of internalization of bound 125 I-ANP to wild-type and mutant NPRA. Approx. 40 % of the 125 I-ANP bound to NPRA was in the intracellular compartments and was resistant to removal by acid wash, in the HEK-293 cells expressing wild-type receptors. In contrast, only approx. 20 % of the 125 I-ANP-bound ligand-receptor complexes were localized in the intracellular compartments in HEK-293 cells expressing GDAY/AAAA mutant NPRA. We observed that a large proportion of ligandreceptor complexes were not internalized, and remained on the plasma membrane of HEK-293 cells expressing GDAY/AAAA mutant receptor.
The release of 125 I-ANP into the culture medium of HEK-293 cells expressing wild-type NPRA increased progressively, reaching 70-80 % with equilibrium after 30 min incubation at 37
• C. However, only 40-45 % of 125 I-ANP was released into the culture medium of HEK-293 cells expressing GDAY/AAAA mutant NPRA ( Figure 4C ). Thus HEK-293 cells expressing GDAY/ AAAA mutant receptors exhibited defective internalization and degradation of bound ANP-NPRA complexes under physiological and steady-state conditions. A quantitative assessment of the intact and degraded ligand was performed by measuring the solubility of 125 I-ANP products in 10 % trichloroacetic acid solution. The trichloroacetic acid precipitates (containing intact ligand) and supernatants (containing degraded ligand products) were separated by centrifugation of trichloroacetic acid-soluble extracts. Higher amounts of both intact and degraded ligand products were found in the culture medium of cells expressing wild-type NPRA when compared with the culture medium of cells expressing GDAY/AAAA mutant receptor. The total released 125 I-ANP was composed of approx. 50-55 % of degraded ligand products and 20-25 % of intact ligand in the culture medium of cells expressing wild-type receptor ( Figure 5 ). On the other hand, the total 125 I-ANP released into the culture medium of cells expressing the mutant receptor was composed of 30-35 % of degraded ligand products and only 10-15 % of intact ligand. The degraded and intact ligand released into the culture medium was quantitatively determined on the basis of the amount of total initial 125 I-ANP bound on the cell surface. Treatment of the HEK-293 cells expressing wild-type and GDAY/AAAA mutant receptors with the lysosomotropic agents chloroquine, ammonium chloride and monensin significantly blocked the degradation of internalized 125 I-ANP-NPRA complexes when compared with untreated control cells ( Figures 6A and 6B) . It is noteworthy that, after treatment with lysosomotropic agents, cells expressing wildtype NPRA ( Figure 6A ) contained almost 50 % more 125 I-ANPbound receptor levels in the intracellular compartments when compared with HEK-293 cells expressing GDAY/AAAA mutant receptor ( Figure 6B ).
Down-regulation of NPRA in HEK-293 cells expressing wild-type and mutant receptors
Confluent HEK-293 cells expressing wild-type, G920A, D921A, Y923A or GDAY/AAAA mutant receptors were pretreated with unlabelled ANP (10 nM) at 37
• C for the indicated time periods and then washed with glycine acidic buffer (pH 3.8) to remove any unbound ligand. Cells were then washed three times with the assay medium (DMEM containing 0.1 % BSA) and allowed to bind 125 I-ANP in 2 ml of fresh assay medium at 4 • C for the indicated time periods. After treating the cells with unlabelled ANP for 60 min, 125 I-ANP-binding sites were decreased by almost 68 + − 5 % in HEK-293 cells expressing wild-type NPRA and by 28 + − 3, 32 + − 3 and 36 + − 4 % in cells expressing G920A, Y923A or GDAY/AAAA mutant receptors respectively (Figure 7) . The HEK-293 cells expressing wild-type or GDAY/AAAA mutant receptors were allowed to bind 125 I-ANP at 4 • C for 1 h. Then, the cells were washed four times with ice-cold assay medium to remove the unbound ligand and then re-incubated in 2 ml of fresh assay medium at 37 • C for 30 min. After incubation, the culture medium was collected and the intact and degraded ligand products were quantified as described in the Materials and methods section. The results represent the means + − S.E.M. for three independent determinations.
mutation D921A had only a minimal effect on the down-regulation of the receptor. Thus the treatment of HEK-293 cells with unlabelled ANP (10 nM) caused a substantial decrease in the ANP-binding capacity of wild-type NPRA; however, the mutant receptors were more resistant to ligand-mediated down-regulation. To confirm independently that a decrease in the functional activity of GDAY/AAAA mutant NPRA in terms of receptor internalization is indeed due to the point mutation created in cDNA, the expressions of both wild-type and mutant receptors were monitored immunologically. Cells expressing the wildtype or mutant NPRA were labelled with [ 35 S]methionine, and receptors were immunoprecipitated utilizing the site-directed polyclonal antibodies raised against the extracellular domain of murine NPRA. The results presented in Figure 8 show that both wild-type and GDAY/AAAA mutant receptors are expressed on the cell surface with almost similar densities, and the mutations created in the C-terminal domain of NPRA did not affect the total receptor expression in HEK-293 cells.
Recycling of internalized wild-type and mutant receptors in HEK-293 cells
To examine the rate of recycling of wild-type, G920A, D921A, Y923A and GDAY/AAAA mutant NPRA, the recombinant HEK-293 cells expressing the respective receptors were treated with a low concentration of trypsin (0.025 %) at 4
• C for 10 min, which abolished cell-surface receptors. To stop the trypsin reaction, cells were treated with soya-bean trypsin inhibitor and washed free of trypsin with serum containing DMEM. Cells were re-incubated in fresh medium and then 125 I-ANP binding was determined. Cells expressing G920A and Y923A mutant receptors 125 I-ANP in 2 ml of fresh assay medium for 60 min at 4 • C as described in the Materials and methods section. The treatment with lysosomotropic agents was maintained throughout the ligand-binding and internalization periods of the experiment. After the binding was completed, cells were washed four times with the assay medium and then placed in 2 ml of fresh medium at 37 • C. After 10 min of internalization and incubation, culture dishes were removed from the medium at 37 • C and placed at 4 • C. The medium was collected and each dish was treated with 2 ml of cold glycine acidic buffer (pH 3.8) for 2 min at 4 • C. After collecting the acid eluate, cells were dissolved in 0.5 M NaOH.
125 I-ANP radioactivity in the acid eluate, cell extract and culture medium was counted to determine the cell-surface-associated, internalized and released 125 I-ANP radioactivity respectively. The results represent the means + − S.E.M. for three independent determinations with triplicate dishes in each experiment. 
Quantitative analysis of the total and intracellular pools of NPRA in HEK-293 cells expressing wild-type and mutant receptors
To examine the possibility whether NPRA was re-inserted into the plasma membrane from the pre-existing intracellular pool, the cell-surface and total receptors were measured in intact and solubilized preparations of HEK-293 cells expressing either wildtype or GDAY/AAAA mutant NPRA (Table 2) . To assess the proportion of both wild-type and GDAY/AAAA mutant receptors in the cell interior, 125 I-ANP binding was measured in solubilized extracts of both trypsin-treated and untreated recombinant HEK-293 cells.
125 I-ANP binding in trypsin-treated and Triton X-100-solubilized HEK-293 cells expressing the wild-type and GDAY/ AAAA mutant receptors indicated that most of the receptors were present on the plasma membrane, and only a small fraction of the receptor population (15-20 %) could be assigned to the preexisting intracellular pool (Table 2) .
DISCUSSION
Results of the present study provide new insights into the structure and function of NPRA by the demonstration that the GDAY motif plays a dual role in receptor internalization into the cell interior and in subsequent recycling of the internalized receptor back to the plasma membrane. The mutations G920A and Y923A in NPRA cDNA markedly attenuated the internalization of mutant receptors by almost 50 % when compared with the wild-type receptor. The mutation D921A showed only a minimal effect; however, Ala 922 failed to decrease the internalization of NPRA. Results of the present study suggest that the regulation of receptor internalization relies largely on Gly 920 and Tyr 923 in the C-terminal domain of NPRA. On the other hand, the mutation D921A significantly attenuated the recycling of the internalized receptor back to the plasma membrane. The role of the NPRA cytoplasmic tail, therefore, is important and comparable with the thyrotropin-stimulating-hormone receptor [22] , insofar as its disruption attenuates receptor internalization. Our previous deletion studies provided evidence that the C-terminal region of NPRA is critical for internalization; however, the involvement of a specific sequence motif in its internalization process was not determined [21] . In the present study, we have extended the results of those previous findings by showing that point mutations within the C-terminal to be necessary for receptor internalization [23] . The sequence NPXY is also present in the cytoplasmic domains of several other membrane proteins, including the insulin receptor [24, 25] . Specifically, tyrosine residues have been suggested to play an important role in the internalization of various hormone receptors [26] [27] [28] .
The internalization of the platelet-activating factor is also regulated by a putative motif DPXXY [29] and that of type 2 vasopressin receptor by the NPXXY sequence [30] . Yet another internalization sequence has been identified in the transferrin receptor, namely YXRF, in which the tyrosine residue is at the first position [31] . Similarly, the YXXL motif has been suggested to play a role in the endocytosis of the LDL receptor-related protein [32] . A common feature of all these internalization motifs, including the currently reported GDAY, is the presence of a tyrosine residue either in the beginning or at the end of the tetrapeptide sequence. Moreover, tyrosine residues in the mannose-6-phosphate receptor [24] and in the haemagglutinin of the influenza virus [29, 33] are also involved in endocytosis, even though they do not occur in the context of NPXY or YXRF consensus sequences. Therefore, if a universal internalization signal exists, it may not be based on a universal amino acid sequence. It has been suggested that the critical characteristics of all these sequences might be their specification of a particular conformation, a tight β-turn in protein structure [31] . The role of the NPEY sequence in receptor internalization has been well recognized. The present study provides evidence for a new signal motif GDAY that is required for both internalization and recycling of NPRA. Our results clearly show that the GDAY sequence is necessary for the internalization of NPRA, but not absolutely sufficient, since the mutation of GDAY to AAAA did not completely block the internalization of NPRA. Gly 920 and Tyr 923 constitute important elements of the GDAY internalization signal. Similarly, the G 950 PLY 953 motif has been suggested to play a role in the internalization of insulin receptor, and Gly 950 and Tyr 953 have been shown to be critical in this process [28] . These authors suggested that a common internalization motif consists of four amino acids with an aromatic residue, especially a tyrosine residue, in the fourth position. It has also been suggested that tyrosine recognition signals may form a small surface loop structure [34] , but this structure differs from that proposed by others in terms of positioning of the tyrosine residue in the loop [35] . Additional studies provided direct evidence that the NPXY sequence in the LDL receptor forms a β-turn structure and showed that peptides containing the NPXY motif assume a reverse-turn structure conformation with tyrosine in the fourth position of the turn [36] . The substitution of tyrosine with the residues known to be inactive in endocytosis resulted in a disruption of the β-turn conformation. A similar approach was also used to obtain evidence that the PPGY sequence of the acid phosphatase cytoplasmic tail forms a type 1 β-turn with the tyrosine residue at position 4 of the turn [37] . All these studies indicated that the tyrosine in the fourth position of internalization signals is critical for receptor endocytosis. Similarly, seven transmembrane Gprotein-linked receptors have a homologous motif, NPXXY, and mutation of this sequence to NPXXA resulted in a complete loss of agonist-induced receptor sequestration [38, 39] . The conserved tyrosine residue was required for internalization of the vasopressin receptor, and the NPXXY sequence represented a general sequestration motif for seven transmembrane G-protein-linked receptors [30] . However, there are certain exceptions to this rule, for example, in mannose-6-phosphate/insulin-like growth factor receptors, the critical tyrosine residue is included at the N-terminal first position of the consensus internalization signal YRHV [34] .
Intriguing was the finding that the single-mutation D921A did not have a major effect on receptor internalization; however, it significantly attenuated the recycling of the internalized receptor back to the plasma membrane. On the other hand, mutation of Gly 920 and Tyr 923 to alanine residues inhibited the internalization of NPRA, but these residues did not have any discernible effect on the recycling of this receptor protein. These findings suggested that the tyrosine-based motif of the GDAY sequence seems to modulate the early internalization process of NPRA, whereas the aspartic residue in GDAY mediates recycling or subsequent sorting events of NPRA. Thus two overlapping motifs within GDAY in the C-terminal domain of NPRA exert different but specific effects on endocytosis and subsequent trafficking of this receptor molecule. Previous studies have demonstrated that acidic motifs such as DSLL in G-protein-coupled receptors act as recycling signals [40 -42] . However, further studies are needed to clarify the dual role of the GDAY motif in the events involved in internalization, recycling and sequestration of NPRA.
Our earlier studies and reports from other laboratories have demonstrated that endogenous NPRA in PC-12 and MA-10 cells, as well as recombinant NPRA in COS-7 and HEK-293 cells, undergo rapid internalization in a ligand-dependent manner [13, 15, 20] . However, one report has indicated that ANP-NPRA complexes were not processed intracellularly in renomedullary interstitial cells, and a rapid dissociation of ligand-receptor complexes probably occurred on ANP binding at 37
• C [43] . It has also been suggested that a trace amount of bound 125 I-ANP may be released from the receptor by neutral endopeptidases in neuroblastoma cells [44] . Studies in our laboratory using recombinant HEK-293 cells firmly established that ANP-NPRA complexes are rapidly internalized, sequestered into the intracellular compartments, and the degraded products are released into the culture medium [15] . After treatment of HEK-293 cells by ANP for 60 min at 37
• C, the 125 I-ANP-binding sites were decreased by almost 68 % in cells expressing wild-type NPRA and by 30-38 % in cells expressing G920A, Y923A and GDAY/AAAA mutant receptors. Our results provide direct evidence that treatment of cells with unlabelled ANP accelerated the disappearance of surface receptors, indicating that ANP-dependent down-regulation of NPRA involves the internalization of ligand-receptor complexes and the mutant receptors were relatively more resistant to ligand-mediated down-regulation. An invaluable experimental paradigm in the elucidation of ligand-dependent desensitization of NPRA would be the use of ANP-induced receptor downregulation. Desensitization and/or inactivation of NPRA have been suggested to occur by mechanisms involving ANP-dependent dephosphorylation [45] . However, the exact mechanisms involving dephosphorylation-dependent inactivation/desensitization of NPRA remain to be established. On the other hand, it is anticipated that desensitization of NPRA might occur intracellularly, and blockade of internalization should prevent this process.
Previously, it has been suggested that ligand-dependent endocytosis and sequestration of NPRA may involve a series of sequential sorting steps through which ligand-receptor complexes could eventually be degraded, the receptor recycled back to the plasma membrane and the ligand be released intact into the cell exterior [15] . Recycling of endocytosed receptor to the plasma membrane and the release of intact ANP into the cell exterior occur at the same time as the processes leading to the degradation of most of the ligand-receptor complexes into lysosomes. Results of the present study suggest that a return in 125 I-ANP binding in trypsin-treated cells implicate that 125 I-ANP binding in trypsintreated cells is due to recycling of NPRA. However, it should be noted that HEK-293 cells expressing G920A and Y923A mutant receptors exhibited almost 35 % decreased 125 I-ANP binding after trypsin treatment when compared with cells expressing wild-type NPRA. On the other hand, cells expressing D921A or triple-mutant GDAY/AAAA receptor showed more than 60 % decrease in 125 I-ANP binding after trypsin treatment when compared with wild-type receptor. The present study provides evidence that, after trypsin treatment, the greater return of 125 I-ANP binding in recombinant wild-type HEK-293 cells is due to a large population of internalized receptors and subsequent recycling to the plasma membrane when compared with cells expressing mutant receptors.
In summary, our results demonstrate that internalization and recycling of NPRA require the GDAY sequence and provide evidence that this tetrapeptide sequence functions as a dual signal motif for both rapid internalization and recycling of NPRA. Although the GDAY signal motif seems to be necessary for rapid internalization and trafficking of NPRA, it is probably not sufficient, since the triple mutation of GDAY to AAAA did not completely block the internalization or recycling of ligand-receptor complexes. Nevertheless, the precise mechanism(s) for liganddependent endocytosis and intracellular routing of NPRA and involvement of adaptor proteins in this process remain to be determined. Furthermore, the connection between the GDAY motif and other internalization signals and, in particular, its role in the internalization of other receptors, remain to be established.
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